{"id":61357,"name":"BRAINFUTURES","slug":"brainfutures","state":"MD","country":"United States of America","description":"Nonprofit advocate for therapeutic treatments for mental health and substance use disorder","totalSpending":220000,"filings":7,"yearlySpending":[{"year":2024,"income":60000},{"year":2025,"income":160000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"BUD","display":"Budget/Appropriations"},{"code":"VET","display":"Veterans"}],"firms":["HOOPER, LUNDY & BOOKMAN, P.C."],"lobbyists":["LISA LAYMAN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Education and advocacy related to treatments for mental health and substance use disorder.","Education and advocacy related to treatments for mental health and substance use disorder.","Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychede","Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychede","Issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies, Issues related to medical adoption of psychedelic drugs "]}